Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes

From MaRDI portal
Revision as of 12:46, 4 February 2024 by Import240129110113 (talk | contribs) (Created automatically from import240129110113)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Publication:3317956

DOI10.2307/2530739zbMath0534.62074OpenAlexW2331522917WikidataQ71386294 ScholiaQ71386294MaRDI QIDQ3317956

Stephen D. Walter, Nicholas E. Day

Publication date: 1984

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/2530739




Related Items (27)

A stochastic model for survival of early prostate cancer with adjustments for leadtime, length bias, and over-detectionScheduling optimal examination times in a simple illness-death modelIdentifiability of the joint distribution of age and tumor size at detection in the presence of screeningQuantification of length‐bias in screening trials with covariate‐dependent test sensitivityTreatment comparisons with screenable endpoints.A Conditional Approach to Measure Mortality Reductions Due to Cancer ScreeningLongitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancersOn the optimal policies of cancer screeningComputer simulation of randomized cancer screening trials to compare methods of estimating lead time and benefit timeA Stochastic Model for Calibrating the Survival Benefit of Screen-Detected CancersEarly detection of disease and scheduling of screening examinationsMultivariate distributions of clinical covariates at the time of cancer detectionDiversity of model approaches for breast cancer screening: a review of model assumptions by The Cancer Intervention and Surveillance Network (CISNET) Breast Cancer GroupsEstimation of Sojourn Time in Chronic Disease Screening Without Data on Interval CasesGeneralized poisson regression modelAn optimal design for simple illness-death modelEstimating distribution of the age of onset of detectable asymptomatic cancerDynamic Forecasting and Control Algorithms of Glaucoma Progression for Clinician Decision SupportEstimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence TrendsProportional Hazards Regression for Cancer StudiesEstimation and Prediction for Cancer Screening Models Using Deconvolution and SmoothingNonparametric Estimation of Asymptomatic Duration from a Randomized Prospective Cancer Screening TrialMLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic ScreeningOn the application of mathematical models in maintenanceScreening for chronic diseases: optimizing lead time through balancing prescribed frequency and individual adherenceModelling multi-stage processes through multivariate distributionsThe genetics of breast and ovarian cancer IV: a model of breast cancer progression




This page was built for publication: Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes